Five years ago, the ICAP initiative on harmonisation and standardisation in the nomenclature of HEp-2 IFA patterns was implemented at the International Workshop on Autoantibodies and Autoimmunity (IWAA) in São Paulo, Brazil. Luis E. C. Andrade, professor at the Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, has been involved from the […]
Recently, a very interesting review article on the diagnostics of bullous dermatoses has been published in Frontiers of Immunology, a peer-reviewed journal. The publication is authored by EUROIMMUN scientists, who were invited to write an expert review article on this important topic. Over the past few years, EUROIMMUN has become a true leader in this
G-protein-coupled receptors (GPCR) are transmembrane proteins involved in various physiological and pathophysiological processes and signalling pathways. Due to their key role, they have been in the focus of science and industry for the past decades to search for new diagnostic markers and pharmaceuticals for the treatment of various diseases. Already around 30% of the therapeutic
In December 2017, the German Society for Rheumatology (DGRh) published their first guideline for the diagnosis and treatment of ANCA-associated forms of vasculitis (AAV) [1]. The AAV encompass granulomatosis with polyangiitis (GPA, formerly Wegener’s granulomatosis), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome), which all occur with autoantibodies against cytoplasmic antigens
On July 26th, EUROIMMUN US organizes a webinar on autoimmune encephalitis. The presenter will be Maarten Titulaer, PhD, professor for neurology at the Erasmus Medical Center in Rotterdam. Previously, he worked with Prof. Josep Dalmau, who first described the anti-NMDAR encephalitis, at the universities of Pennsylvania and Barcelona, investigating anti-NMDAR and anti-LGI1 antibodies. Registration for the webinar
